schliessen

Filtern

 

Bibliotheken

Nanoparticle vaccines

Highlights • Nanotechnology offers new vistas for the engineering of vaccine formulations. • Nanoparticles of various size, shape, surface and composition are being explored. • Nanoparticles function as delivery system or immune potentiator. • Greater fundamental understanding is needed and will ope... Full description

Journal Title: Vaccine 2013, Vol.32 (3), p.327-337
Main Author: Zhao, Liang
Other Authors: Seth, Arjun , Wibowo, Nani , Zhao, Chun-Xia , Mitter, Neena , Yu, Chengzhong , Middelberg, Anton P.J
Format: Electronic Article Electronic Article
Language: English
Subjects:
Quelle: Alma/SFX Local Collection
Publisher: Kidlington: Elsevier Ltd
ID: ISSN: 0264-410X
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_proquest_miscellaneous_1516750772
title: Nanoparticle vaccines
format: Article
creator:
  • Zhao, Liang
  • Seth, Arjun
  • Wibowo, Nani
  • Zhao, Chun-Xia
  • Mitter, Neena
  • Yu, Chengzhong
  • Middelberg, Anton P.J
subjects:
  • Adjuvant
  • Adjuvants, Immunologic - pharmacology
  • Adjuvants, Immunologic - therapeutic use
  • Allergy and Immunology
  • Applied microbiology
  • Biological and medical sciences
  • Disease prevention
  • Drug delivery systems
  • Environmental
  • Fundamental and applied biological sciences. Psychology
  • Humans
  • Immunology
  • Infectious Diseases
  • Microbiology
  • Microbiology(all)
  • Molecular Medicine
  • Nanoparticle
  • Nanoparticles
  • Nanoparticles - therapeutic use
  • Nanotechnology
  • Nanovaccinology
  • Occupational Health
  • Public Health
  • Vaccination - methods
  • Vaccine
  • Vaccines
  • Vaccines - administration & dosage
  • Vaccines - immunology
  • Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
  • veterinary(all)
ispartof: Vaccine, 2013, Vol.32 (3), p.327-337
description: Highlights • Nanotechnology offers new vistas for the engineering of vaccine formulations. • Nanoparticles of various size, shape, surface and composition are being explored. • Nanoparticles function as delivery system or immune potentiator. • Greater fundamental understanding is needed and will open new opportunities.
language: eng
source: Alma/SFX Local Collection
identifier: ISSN: 0264-410X
fulltext: fulltext
issn:
  • 0264-410X
  • 1873-2518
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK2.8186367
LOCALfalse
PrimoNMBib
record
control
sourceidgale_opena
recordidTN_cdi_proquest_miscellaneous_1516750772
sourceformatXML
sourcesystemPC
galeidA354762003
sourcerecordidA354762003
originalsourceidFETCH-LOGICAL-1663t-4a07e82b22b59cca010a41c081479b64bdb4ed9d8acf7ca994e02548b63e165a3
addsrcrecordideNqFkt1rFDEUxQdR7Lb66KMiSMGXHXPzOUFQSvGjUPRBBd_CncwdyTqb2Sazhf73Zti1hX1Z8jBk-J3DyT23ql4Cq4GBfreqb9H7EKnmDEQNUDNtH1ULaIxYcgXN42rBuJZLCez3SXWa84oxpgTYp9UJl9yqhjWL6sU3jOMG0xT8QK_3lvlZ9aTHIdPz_fes-vX508_Lr8vr71-uLi-ul6C1mJYSmaGGt5y3ynqPDBhK8KwBaWyrZdu1kjrbNeh749FaSYwr2bRaEGiF4qy62vmOG4oYErlNCmtMd27E4LpIk2sxU7k5ZVEw0YEk6AE7ZbTk1LRdsddAJIvX253XJo03W8qTW4fsaRgw0rjNDhRoo5gx_DgqLTPALTcFfXOArsZtimUoxVAZEHMZhap31B8cyIXYj1NCX05H6-DHSH0o_y-EkkZzxkQRqJ3ApzHnRP39w4G52dKt3L4MN_frAFzpt-he7eNs2zV196r_hRbgfA9g9jj0CaMP-YFruLbKqMK9Pwjgw4RTGGNJHoajMT7u1FSW4zZQctkHip660qGfXDeGow4fDhz8EGIokf_SHeWHIbvMHXM_5lWeNxnEPG-w4h-O3-ox
sourcetypeOpen Access Repository
isCDItrue
recordtypearticle
pqid1557131016
display
typearticle
titleNanoparticle vaccines
sourceAlma/SFX Local Collection
creatorZhao, Liang ; Seth, Arjun ; Wibowo, Nani ; Zhao, Chun-Xia ; Mitter, Neena ; Yu, Chengzhong ; Middelberg, Anton P.J
creatorcontribZhao, Liang ; Seth, Arjun ; Wibowo, Nani ; Zhao, Chun-Xia ; Mitter, Neena ; Yu, Chengzhong ; Middelberg, Anton P.J
descriptionHighlights • Nanotechnology offers new vistas for the engineering of vaccine formulations. • Nanoparticles of various size, shape, surface and composition are being explored. • Nanoparticles function as delivery system or immune potentiator. • Greater fundamental understanding is needed and will open new opportunities.
identifier
0ISSN: 0264-410X
1EISSN: 1873-2518
2DOI: 10.1016/j.vaccine.2013.11.069
3PMID: 24295808
4CODEN: VACCDE
languageeng
publisherKidlington: Elsevier Ltd
subjectAdjuvant ; Adjuvants, Immunologic - pharmacology ; Adjuvants, Immunologic - therapeutic use ; Allergy and Immunology ; Applied microbiology ; Biological and medical sciences ; Disease prevention ; Drug delivery systems ; Environmental ; Fundamental and applied biological sciences. Psychology ; Humans ; Immunology ; Infectious Diseases ; Microbiology ; Microbiology(all) ; Molecular Medicine ; Nanoparticle ; Nanoparticles ; Nanoparticles - therapeutic use ; Nanotechnology ; Nanovaccinology ; Occupational Health ; Public Health ; Vaccination - methods ; Vaccine ; Vaccines ; Vaccines - administration & dosage ; Vaccines - immunology ; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) ; veterinary(all)
ispartofVaccine, 2013, Vol.32 (3), p.327-337
rights
0The Authors
12013 The Authors
22015 INIST-CNRS
3Copyright © 2013 The Authors. Published by Elsevier Ltd.. All rights reserved.
4COPYRIGHT 2014 Elsevier B.V.
5Copyright Elsevier Limited Jan 9, 2014
lds50peer_reviewed
oafree_for_read
citedbyFETCH-LOGICAL-1663t-4a07e82b22b59cca010a41c081479b64bdb4ed9d8acf7ca994e02548b63e165a3
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
thumbnail$$Usyndetics_thumb_exl
backlink
0$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28269575$$DView record in Pascal Francis
1$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24295808$$D View this record in MEDLINE/PubMed
search
creatorcontrib
0Zhao, Liang
1Seth, Arjun
2Wibowo, Nani
3Zhao, Chun-Xia
4Mitter, Neena
5Yu, Chengzhong
6Middelberg, Anton P.J
title
0Nanoparticle vaccines
1Vaccine
addtitleVaccine
descriptionHighlights • Nanotechnology offers new vistas for the engineering of vaccine formulations. • Nanoparticles of various size, shape, surface and composition are being explored. • Nanoparticles function as delivery system or immune potentiator. • Greater fundamental understanding is needed and will open new opportunities.
subject
0Adjuvant
1Adjuvants, Immunologic - pharmacology
2Adjuvants, Immunologic - therapeutic use
3Allergy and Immunology
4Applied microbiology
5Biological and medical sciences
6Disease prevention
7Drug delivery systems
8Environmental
9Fundamental and applied biological sciences. Psychology
10Humans
11Immunology
12Infectious Diseases
13Microbiology
14Microbiology(all)
15Molecular Medicine
16Nanoparticle
17Nanoparticles
18Nanoparticles - therapeutic use
19Nanotechnology
20Nanovaccinology
21Occupational Health
22Public Health
23Vaccination - methods
24Vaccine
25Vaccines
26Vaccines - administration & dosage
27Vaccines - immunology
28Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
29veterinary(all)
issn
00264-410X
11873-2518
fulltexttrue
rsrctypearticle
creationdate2013
recordtypearticle
recordideNqFkt1rFDEUxQdR7Lb66KMiSMGXHXPzOUFQSvGjUPRBBd_CncwdyTqb2Sazhf73Zti1hX1Z8jBk-J3DyT23ql4Cq4GBfreqb9H7EKnmDEQNUDNtH1ULaIxYcgXN42rBuJZLCez3SXWa84oxpgTYp9UJl9yqhjWL6sU3jOMG0xT8QK_3lvlZ9aTHIdPz_fes-vX508_Lr8vr71-uLi-ul6C1mJYSmaGGt5y3ynqPDBhK8KwBaWyrZdu1kjrbNeh749FaSYwr2bRaEGiF4qy62vmOG4oYErlNCmtMd27E4LpIk2sxU7k5ZVEw0YEk6AE7ZbTk1LRdsddAJIvX253XJo03W8qTW4fsaRgw0rjNDhRoo5gx_DgqLTPALTcFfXOArsZtimUoxVAZEHMZhap31B8cyIXYj1NCX05H6-DHSH0o_y-EkkZzxkQRqJ3ApzHnRP39w4G52dKt3L4MN_frAFzpt-he7eNs2zV196r_hRbgfA9g9jj0CaMP-YFruLbKqMK9Pwjgw4RTGGNJHoajMT7u1FSW4zZQctkHip660qGfXDeGow4fDhz8EGIokf_SHeWHIbvMHXM_5lWeNxnEPG-w4h-O3-ox
startdate2013
enddate2013
creator
0Zhao, Liang
1Seth, Arjun
2Wibowo, Nani
3Zhao, Chun-Xia
4Mitter, Neena
5Yu, Chengzhong
6Middelberg, Anton P.J
general
0Elsevier Ltd
1Elsevier
2Elsevier B.V
3Elsevier Limited
4Elsevier BV
scope
06I.
1AAFTH
2IQODW
3CGR
4CUY
5CVF
6ECM
7EIF
8NPM
9AAYXX
10CITATION
11BSHEE
123V.
137QL
147RV
157T2
167T5
177U9
187X7
197XB
2088C
2188E
228AO
238C1
248FE
258FH
268FI
278FJ
288FK
298G5
30ABUWG
31AZQEC
32BBNVY
33BENPR
34BHPHI
35C1K
36DWQXO
37FYUFA
38GHDGH
39GNUQQ
40GUQSH
41H94
42HCIFZ
43K9-
44K9.
45KB0
46LK8
47M0R
48M0S
49M0T
50M1P
51M2O
52M7N
53M7P
54MBDVC
55NAPCQ
56PQEST
57PQQKQ
58PQUKI
59Q9U
607X8
61BOBZL
62CLFQK
sort
creationdate2013
titleNanoparticle vaccines
authorZhao, Liang ; Seth, Arjun ; Wibowo, Nani ; Zhao, Chun-Xia ; Mitter, Neena ; Yu, Chengzhong ; Middelberg, Anton P.J
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-1663t-4a07e82b22b59cca010a41c081479b64bdb4ed9d8acf7ca994e02548b63e165a3
rsrctypearticles
prefilterarticles
languageeng
creationdate2013
topic
0Adjuvant
1Adjuvants, Immunologic - pharmacology
2Adjuvants, Immunologic - therapeutic use
3Allergy and Immunology
4Applied microbiology
5Biological and medical sciences
6Disease prevention
7Drug delivery systems
8Environmental
9Fundamental and applied biological sciences. Psychology
10Humans
11Immunology
12Infectious Diseases
13Microbiology
14Microbiology(all)
15Molecular Medicine
16Nanoparticle
17Nanoparticles
18Nanoparticles - therapeutic use
19Nanotechnology
20Nanovaccinology
21Occupational Health
22Public Health
23Vaccination - methods
24Vaccine
25Vaccines
26Vaccines - administration & dosage
27Vaccines - immunology
28Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
29veterinary(all)
toplevel
0peer_reviewed
1online_resources
creatorcontrib
0Zhao, Liang
1Seth, Arjun
2Wibowo, Nani
3Zhao, Chun-Xia
4Mitter, Neena
5Yu, Chengzhong
6Middelberg, Anton P.J
collection
0ScienceDirect Open Access Titles
1Elsevier:ScienceDirect:Open Access
2Pascal-Francis
3Medline
4MEDLINE
5MEDLINE (Ovid)
6MEDLINE
7MEDLINE
8PubMed
9CrossRef
10Academic OneFile (A&I only)
11ProQuest Central (Corporate)
12Bacteriology Abstracts (Microbiology B)
13Nursing & Allied Health Database
14Health and Safety Science Abstracts (Full archive)
15Immunology Abstracts
16Virology and AIDS Abstracts
17Health & Medical Collection
18ProQuest Central (purchase pre-March 2016)
19Healthcare Administration Database (Alumni)
20Medical Database (Alumni Edition)
21ProQuest Pharma Collection
22Public Health Database
23ProQuest SciTech Collection
24ProQuest Natural Science Collection
25Hospital Premium Collection
26Hospital Premium Collection (Alumni Edition)
27ProQuest Central (Alumni) (purchase pre-March 2016)
28Research Library (Alumni Edition)
29ProQuest Central (Alumni Edition)
30ProQuest Central Essentials
31Biological Science Collection
32ProQuest Central
33Natural Science Collection
34Environmental Sciences and Pollution Management
35ProQuest Central Korea
36Health Research Premium Collection
37Health Research Premium Collection (Alumni)
38ProQuest Central Student
39Research Library Prep
40AIDS and Cancer Research Abstracts
41SciTech Premium Collection
42Consumer Health Database (Alumni Edition)
43ProQuest Health & Medical Complete (Alumni)
44Nursing & Allied Health Database (Alumni Edition)
45ProQuest Biological Science Collection
46Consumer Health Database
47Health & Medical Collection (Alumni Edition)
48Healthcare Administration Database
49Medical Database
50Research Library
51Algology Mycology and Protozoology Abstracts (Microbiology C)
52Biological Science Database
53Research Library (Corporate)
54Nursing & Allied Health Premium
55ProQuest One Academic Eastern Edition
56ProQuest One Academic
57ProQuest One Academic UKI Edition
58ProQuest Central Basic
59MEDLINE - Academic
60OpenAIRE (Open Access)
61OpenAIRE
jtitleVaccine
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
au
0Zhao, Liang
1Seth, Arjun
2Wibowo, Nani
3Zhao, Chun-Xia
4Mitter, Neena
5Yu, Chengzhong
6Middelberg, Anton P.J
formatjournal
genrearticle
ristypeJOUR
atitleNanoparticle vaccines
jtitleVaccine
addtitleVaccine
date2013
risdate2013
volume32
issue3
spage327
epage337
pages327-337
issn0264-410X
eissn1873-2518
codenVACCDE
abstractHighlights • Nanotechnology offers new vistas for the engineering of vaccine formulations. • Nanoparticles of various size, shape, surface and composition are being explored. • Nanoparticles function as delivery system or immune potentiator. • Greater fundamental understanding is needed and will open new opportunities.
copKidlington
pubElsevier Ltd
pmid24295808
doi10.1016/j.vaccine.2013.11.069
oafree_for_read